FUJIFILM Releases EN-840T Double Balloon Enteroscopy Scope

FUJIFILM Healthcare Americas Corporation has introduced to market the EN-840T Double Balloon Enteroscopy (DBE) scope, an endoscopic imaging technology that enables access to the entire small intestine for diagnosis and therapeutic intervention. The EN-840T DBE scope represents a major update to Fujifilm’s pioneering Double Balloon Enteroscopy  technology, according to the company. 

“The small intestine is one of the most challenging areas in patient anatomy to access in GI endoscopy,” said Tai Fujita, vice president, Endoscopy Division, FUJIFILM Healthcare Americas Corporation. “By continuing to develop and enhance our double balloon enteroscopy technologies, we are empowering endoscopists and GI physicians to unlock access to difficult to reach pathways within the digestive tract, while simultaneously assisting with diagnosis and treatment for a wide array of diseases of the small intestine, including Crohn’s disease, gastrointestinal bleeding, and removal of small bowel polyps, among others.”  

The EN-840T DBE Scope’s 3.2 mm diameter working channel suits various procedures requiring hemostasis and balloon dilation, providing greater suction performance than that of conventional models. It also allows blood or mucus to be aspirated while a therapeutic device is inserted, enabling quicker hemostasis, the company notes. The large working channel allows for easier insertion and catheter removal before and after stricture dilatation. The scope features a dedicated forward water jet channel for irrigation and to help quickly clear debris like blood and mucus on the mucous membranes for clearer bowel wall visualization.   

A CMOS (Complementary Metal-Oxide-Semiconductor) image sensor in the EN-840T DBE scope ensures vivid, HD, high-quality images, providing speed and clarity for diagnosis. The scope also leverages LED multi-light technology along with Fujifilm’s Linked Color Imaging (LCI) and Blue Light Imaging (BLI) modes to provide endoscopists with unparalleled visualization and enable optimal detection during small bowel procedures. Fujifilm also pioneered LED Multi-light technology for endoscopic imaging, allowing doctors to easily change the light modes they use and is clinically proven to improve colorectal lesion and adenoma detection rates.¹ 

“This scope is a major step forward for deep enteroscopy,” said Daniel J. Stein, M.D., of Brigham and Women’s Hospital. “Improvements in all areas—scope dynamics, optics and irrigation will empower physicians to really push the envelope for deep small bowel diagnostics and therapeutics.” 

Critical for small bowel and intestine procedures, the scope provides adaptive bending and advanced force transmission technology for improved access and scope maneuverability in challenging anatomy. Adaptative scope bending also supports deeper insertion even through post-surgical intestinal tract adhesions. Additionally, the G7 scope handle grip design is intended to minimize stress and enable intuitive operation.   

Fujifilm will demonstrate the EN-840T DBE scope at the 2025 Digestive Disease Week annual conference and exhibition in booth 4729, held May 3-6 in San Diego. 

FUJIFILM Healthcare Americas Corporation is a comprehensive healthcare company with an extensive range of technology and expertise in detecting, diagnosing, and treating diseases. Fujifilm’s portfolio includes solutions spanning diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in-vitro diagnostics. The company is headquartered in Lexington, Mass.  

FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver products and services through the four key business segments: healthcare, electronics, business innovation, and imaging with more than 70,000 employees. Under its medium-term management plan, VISION2030, ending in FY2030, the company aspires to create value for various stakeholders as a collection of global leading businesses and achieve 4 trillion yen ($29 billion) in global revenue.   

* Fujifilm’s EN-840T DBE Scope is also available in Japan and Europe.  

Reference
¹ Suzuki S, Aniwan S, Chiu HM, Laohavichitra K, Chirapongsathorn S, et al; ATLAS Trial Group. 2023. Linked-Color Imaging detects more colorectal adenoma and serrated lesions: An international randomized controlled trial. Clin Gastroenterol Hepatol 21(6):1493-1502.e4, PMID: 36328306.